| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantages of a third-generation β-blocker in patients with diabetes mellitus
|
Bell, David S.H
|
|
2004
|
93 |
9S1 |
p. 49-52
4 p.
|
artikel
|
| 2 |
β-blockers in hypertension: is carvedilol different?
|
Messerli, Franz H
|
|
2004
|
93 |
9S1 |
p. 7-12
6 p.
|
artikel
|
| 3 |
Cardiac remodeling in coronary artery disease
|
Sharpe, Norman
|
|
2004
|
93 |
9S1 |
p. 17-20
4 p.
|
artikel
|
| 4 |
Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial: carvedilol in severe heart failure
|
Fowler, Michael B
|
|
2004
|
93 |
9S1 |
p. 35-39
5 p.
|
artikel
|
| 5 |
Commentary on the Carvedilol or Metoprolol European Trial (COMET)
|
Poole-Wilson, Philip A
|
|
2004
|
93 |
9S1 |
p. 40-42
3 p.
|
artikel
|
| 6 |
Introduction
|
Gheorghiade, Mihai
|
|
2004
|
93 |
9S1 |
p. 1-2
2 p.
|
artikel
|
| 7 |
Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program
|
Gilbert, Edward M
|
|
2004
|
93 |
9S1 |
p. 30-34
5 p.
|
artikel
|
| 8 |
Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN)
|
Colucci, Wilson S
|
|
2004
|
93 |
9S1 |
p. 13-16
4 p.
|
artikel
|
| 9 |
Pharmacology of carvedilol
|
Dulin, Brian
|
|
2004
|
93 |
9S1 |
p. 3-6
4 p.
|
artikel
|
| 10 |
Practical guidelines to optimize effectiveness of β-blockade in patients postinfarction and in those with chronic heart failure
|
Sackner-Bernstein, Jonathan D
|
|
2004
|
93 |
9S1 |
p. 69-73
5 p.
|
artikel
|
| 11 |
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure
|
Gattis, Wendy A
|
|
2004
|
93 |
9S1 |
p. 74-76
3 p.
|
artikel
|
| 12 |
Reappraisal of β-blocker therapy in the acute and chronic post–myocardial infarction period
|
Borrello, Franceso
|
|
2004
|
93 |
9S1 |
p. 21-29
9 p.
|
artikel
|
| 13 |
Role of carvedilol in atrial fibrillation: insights from clinical trials
|
Gheorghiade, Mihai
|
|
2004
|
93 |
9S1 |
p. 53-57
5 p.
|
artikel
|
| 14 |
Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes
|
Fonarow, Gregg C
|
|
2004
|
93 |
9S1 |
p. 77-81
5 p.
|
artikel
|
| 15 |
Special considerations for carvedilol use in heart failure
|
Yancy, Clyde W
|
|
2004
|
93 |
9S1 |
p. 64-68
5 p.
|
artikel
|
| 16 |
Tolerability of carvedilol in heart failure: clinical trials experience
|
Krum, Henry
|
|
2004
|
93 |
9S1 |
p. 58-63
6 p.
|
artikel
|
| 17 |
Ventricular remodeling in heart failure and the effect of β-blockade
|
Udelson, James E
|
|
2004
|
93 |
9S1 |
p. 43-48
6 p.
|
artikel
|
Tijdschrift beschrijving